APOLLO HOSPITALS ENTER. L vs MEDICAMEN BIOTECH LIMITED
A side-by-side comparison of APOLLO HOSPITALS ENTER. L (APOLLOHOSP) and MEDICAMEN BIOTECH LIMITED (MEDICAMEQ) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.
On the numbers, APOLLO HOSPITALS ENTER. L leads APOLLOHOSP vs MEDICAMEQ on 10 of 14 metrics. See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).
- Valuation13
- Profitability40
- Growth20
- Size & financial health31
Each axis shows this group's split of that metric, scaled so the leader sits at the edge. Relative to each other, not an absolute score.
Valuation
MEDICAMEQ takes 3/4How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.
Profitability
APOLLOHOSP takes 4/4How efficiently each company turns capital and sales into profit. Higher is better.
Growth
APOLLOHOSP takes 2/2Three-year compounded growth. Faster-growing businesses can justify a higher valuation.
Size & financial health
APOLLOHOSP takes 3/4Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.
- + ["Company has delivered good profit growth of 76.2% CAGR over last 5 years", "Company has been maintaining a healthy dividend payout of 17.7%"]
- − ["Stock is trading at 13.4 times its book value", "Company might be capitalizing the interest cost"]
- + ["Company is expected to give good quarter"]
- − ["The company has delivered a poor sales growth of 11.9% over past five years.", "Company has a low return on equity of 4.23% over last 3 years.", "Dividend payout has been low at 14.5% of profits over last 3 years", "Company has high debtors of 151 days."]
This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.